© 2022 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
November 24, 2020
Investigators reviewed visual acuity, multi-modal retinal imaging, electroretinography, family history.
November 17, 2020
November 12, 2020
DME diagnosis plays no role in determining whether patients will receive injection.
November 11, 2020
Elevated pressure can lead to irreversible optic nerve damage, vision loss
November 10, 2020
Optics block out-of-focus and stray light, allow continuum of vision.
November 09, 2020
Device allows visually impaired to recognize shapes, distinguish between light and dark.
November 06, 2020
Research could lead to a novel therapeutic strategy for blinding disease
November 05, 2020
Study examines use of fluocinolone acetonide for treating DME in patients.
October 30, 2020
Investigators research safety, efficacy of endolaserless vitrectomy.
October 29, 2020
October 11, 2020
With three days of content, expo will kick off November 13.
See page 6 of our October 1 issue: https://bit.ly/3iP5ERY
October 06, 2020
The FEMCAT study found that FLACS is not superior to conventional approach
October 05, 2020
In study, treatment demonstrates promising biologic activity, safety profile
October 02, 2020
High-quality images can be useful for early diagnosis, prognosis, monitoring
October 01, 2020
Check out the latest cartoon!
Stealth BioTherapeutics announces data from Phase 2 study of geographic atrophy candidate
Ocuphire announces positive topline results from LYNX-1 Phase 3 trial
Kala reaches deal to sell Eysuvis, Inveltys to Alcon